CNBC's Bertha Coombs reports on Obamacare rate increase requests which could have consumers paying much higher prices. The "FMHR" traders weigh in on what this could do for health care stocks. » Read More
Stocks pared their losses on Wednesday after a weak open, but the market remained skittish after Moody's put Portugal's debt rating on review. Dan Denbow, co-portfolio manager of USAA Precious Metals & Minerals Fund and Jim Meyer, chief investment officer and co-founder of Tower Bridge Advisors shared their insights.
Markets could see a correction in the June to July time frame, said Tobias Levkovich, chief U.S. equity strategist at Citi. He shared his market outlook with investors.
The Dow erased nearly all of its gains Monday, dragged down by the financial sector amid worries about financial reform. Caterpillar led the Dow's gainers, up more than 4 percent.
The Dow remained higher in mid-afternoon Monday amid a flurry of new M&A activity and an earnings beat from Caterpillar. But there was some weakness in the energy, banking and health-care sectors, which dragged on the S&P and Nasdaq.
Stocks ended higher Tuesday, led by energy and financials. But IBM and Goldman Sachs declined.
American corporations cut back on a number executive perks in 2009, in response to the economic downturn. One benefit, however, remained a top priority: personal security for chief executives.
The S&P Health Care Index has been seeing a boost from the health care bill. Will the stocks continue to get a lift from the new legislation—and how should you play the sector? Ipsita Smolinski, president and health care analyst at Capitol Street, and Carl McDonald, health care analyst and managed care analyst at Oppenheimer, discussed their views.
House Democrats are pushing to pass the health care bill as Pres. Obama seeks to rally recalcitrant congresspeople. Which stocks and sectors actually stand to benefit from the bill? Les Funtleyder, health care strategist at Miller Tabak, Jason Gurda, managed care analyst at Leerink Swann and Ralph Giacobbe, analyst at Credit Suisse First Boston offered their insights and investment recommendations.
February chain stores' sales and weekly jobless claims data, due ahead of the opening bell on Thursday, will likely feel the chill from winter storms.
Stocks logged a solid 3-percent gain for February but the momentum faded in the past week as confidence in the recovery began to falter. Financials and health-care stocks were among the best performers; consumer-focused stocks fell out of favor.
The Dow fell below 10,000 for the first time since last November amid worries about the US job market and Europe's ability to get a grip on its debt. The blue-chip index is now down over 4 percent for the year.
Futures fell sharply Thursday after a surprise jump in jobless claims, a disappointing signal on the employment front ahead of Friday's jobs report.
What follows is a roundup of corporate earnings reports for Thursday, Feb. 4.
It’s been a tough week for the bulls as the Dow has had its worst two-day drop since June, the S&P had its worst one-day drop since October of last year. Are the markets headed for a correction? Joe Battipaglia, private client market strategist at Stifel Nicolaus, shared his insights.
With a slew of banks set to report earnings this week, the Fast Money desk is closely watching the action in the financials. Is weakness already priced in?
It has been over a month and a half since the US House of Representatives passed its version of health care reform and today, the Senate passed its bill. Now the two bills must be reconciled and the debate will continue to heat up. Here are the biggest S&P Health Care gainers and losers over the past 6 months.
Futures mostly shrugged off news that weekly unemployment claims hit their lowest level in 15 months, but stocks were still poised for a gain in a holiday-shortened session Thursday.
Our traders are good but you knew that! Check out their latest picks that paid in a regular feature we call "Quicker Than The Ticker."
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Senate Democrats came to an agreement on Tuesday to replace the controversial government-run public insurance option with a scaled-back non-profit plan. So which companies in the health care sector are worth investing in? John Sullivan, director of research and health care investment strategist at Leerink Swann, shared his insight.